For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Zomedica Corp’s stock clocked out at $0.13, up 0.87% from its previous closing price of $0.13. In other words, the price has increased by $0.87 from its previous closing price. On the day, 2.63 million shares were traded. ZOM stock price reached its highest trading level at $0.1318 during the session, while it also had its lowest trading level at $0.1261.
Ratios:
To gain a deeper understanding of ZOM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.68 and its Current Ratio is at 11.39. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 05 ’24 when HEATON LARRY C II bought 100,000 shares for $0.12 per share. The transaction valued at 12,500 led to the insider holds 400,000 shares of the business.
POWERS JOHNNY D bought 100,000 shares of ZOM for $12,900 on Aug 28 ’24. The Director now owns 2,325,000 shares after completing the transaction at $0.13 per share. On Aug 20 ’24, another insider, Blair Anthony K, who serves as the COO of the company, bought 100,000 shares for $0.14 each. As a result, the insider paid 14,200 and bolstered with 250,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 127637808 and an Enterprise Value of 48119564. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.81 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 1.845 whereas that against EBITDA is -1.637.
Stock Price History:
Over the past 52 weeks, ZOM has reached a high of $0.23, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -11.08%, while the 200-Day Moving Average is calculated to be -14.67%.
Shares Statistics:
It appears that ZOM traded 3.27M shares on average per day over the past three months and 3396210 shares per day over the past ten days. A total of 979.95M shares are outstanding, with a floating share count of 962.51M. Insiders hold about 1.77% of the company’s shares, while institutions hold 8.60% stake in the company. Shares short for ZOM as of 1723680000 were 51143477 with a Short Ratio of 15.63, compared to 1721001600 on 58142254. Therefore, it implies a Short% of Shares Outstanding of 51143477 and a Short% of Float of 5.21.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $6.26M. It ranges from a high estimate of $8.18M to a low estimate of $8.18M. As of the current estimate, Zomedica Corp’s year-ago sales were $5.48MFor the next quarter, 1 analysts are estimating revenue of $6.13M. There is a high estimate of $8.35M for the next quarter, whereas the lowest estimate is $8.35M.
A total of 1 analysts have provided revenue estimates for ZOM’s current fiscal year. The highest revenue estimate was $34.1M, while the lowest revenue estimate was $34.1M, resulting in an average revenue estimate of $34.1M. In the same quarter a year ago, actual revenue was $25.19MBased on 1 analysts’ estimates, the company’s revenue will be $39.19M in the next fiscal year. The high estimate is $39.19M and the low estimate is $39.19M.
